Cedars-Sinai Medical Center

West Hollywood, California 90069

2 studies enrolling now · 14 studies all time

What they study most

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Bladder Cancer, Breast Cancer, COVID-19, Carcinoma, Non-Small-Cell Lung, Castration Resistant Prostate Cancer, Cholangiocarcinoma, Colorectal Cancer, Dietary Habits, Ductal Breast Carcinoma In Situ, Endometrial Cancer

Studies at this site

• Nutrition for Precision Health, Powered by the All of Us — Recruiting now
• Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators — Recruiting now
• A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer — Running, not enrolling
• A Study of Amivantamab Subcutaneous (SC) Administration for the Treatment of Advanced Solid Malignancies — Running, not enrolling
• INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors — Completed
• Study of Cilofexor in Adults With Primary Sclerosing Cholangitis — Stopped early
• Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy — Completed
• Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) — Stopped early
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation — Completed
• Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis — Completed